Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • FDA To Speed Up Approval Of Laboratory-Developed SARS-CoV-2 Tests

    FierceHealthcare (11/16, King) reports that the FDA “will speed up the approval of laboratory-developed [SARS-CoV-2] tests developed by universities and hospital systems, Trump administration officials said.” The FDA “will get help from the National Cance...
    Full Article
  • Performing Sequential Non-Invasive Tests May More Accurately Measure Severity Of Fatty Liver Than Single Or Simultaneous Tests, Research Suggests

    Healio (11/15, Altersitz) reports, “Performing sequential non-invasive tests more accurately measured severity of fatty liver than single tests or simultaneous tests,” investigators concluded after analyzing data from “all participants in the REGENERATE s...
    Full Article
  • Black Patients Less Likely Than White Patients To Receive Eradication Testing After H. Pylori Infection Treatment, Study Indicates

    Gastroenterology Advisor (11/16, Narozniak) reports, “Black patients were found to be 38% less likely to receive eradication testing after receiving treatment for Helicobacter pylori infection compared with white patients,” investigators concluded. The fi...
    Full Article
  • Researchers Say There Is An Average 380-Day Delay Between Abnormal Anal Pap Test Result After HIV Diagnosis And The Recommended Follow-Up Of High-Resolution Anoscopy

    Medscape (11/16, Boerner, Subscription Publication) reports researchers found “it took an average of 380 days for people who had received an abnormal anal Pap test result after having been diagnosed with HIV to undergo high-resolution anoscopy (HRA), whic...
    Full Article
  • More Than A Million Children Have Tested Positive For SARS-CoV-2 In The US Since The Pandemic Began

    CNN (11/16, Fox, LaMotte) reports more than a million children have tested positive for SARS-CoV-2 in the US since the pandemic began, according to the AAP and the Children’s Hospital Association. In a joint statement, the groups said, “As of Nov. 12, a t...
    Full Article
  • Toxoplasmosis Infection May Confer Certain Level Of Protection Against MS, Research Indicates

    Multiple Sclerosis News Today (11/16, Inacio) reports research suggests “toxoplasmosis, an infection by the parasite Toxoplasma gondii, may confer a certain level of protection against multiple sclerosis (MS).” Researchers “collected blood samples from 12...
    Full Article
  • Public Health Officials Say The Chapare Virus In Bolivia Can Move From Person To Person

    HealthDay (11/16, Thompson) reports public health officials say that the Chapare virus can spread from person to person, as evidenced by the transmission of the virus from an initial patient in Boliva last year to multiple healthcare workers. The virus fr...
    Full Article
  • Experimental Herpes Vaccine Appears Effective In Lab Animals, Study Indicates

    HealthDay (11/16) reports scientists have created “an experimental herpes vaccine that uses a genetically modified version of the” herpes simplex virus that prevents the virus from “hiding out in nervous system cells in order to elude the immune system.”...
    Full Article
  • Some Countries And Cities Now Testing Sewage From Individual Buildings To Track Coronavirus

    Reuters (11/13, Martell) reported that for months, some countries and cities have been “testing sewage for evidence of the coronavirus, hoping to detect rising infections early,” but “now some researchers are fine-tuning that strategy by moving upstream t...
    Full Article
  • Some Criticize China’s New Testing Policy Requiring Inbound Travelers To Present Negative Results From An Antibody Test

    The New York Times (11/13, Wu) reported at the end of October, China announced a new testing policy that “requires inbound travelers to present negative results from an antibody test – which can neither reliably rule out infections nor prove that a person...
    Full Article
  • Neurofilament Light Chain Appears Promising As Prognostic Biomarker In GBS, Study Indicates

    MedPage Today (11/13, George) reported, “Neurofilament light chain (NfL), a measure of axonal damage, showed promise as a prognostic biomarker in Guillain-Barré syndrome (GBS),” investigators concluded in a study that linked “high serum NfL levels in GBS...
    Full Article
  • Using Genetic Markers With Metabolic Risk Factors May Predict Individual Patient’s Risk For Developing Liver-Related Events Due To NAFLD, Investigators Conclude

    Healio (11/15, Altersitz) reported, “Using genetic markers with metabolic risk factors can predict an individual patient’s risk for developing liver- related events due to non-alcoholic fatty liver disease [NAFLD],” investigators concluded in a study that...
    Full Article
  • Deaths From COVID-19 Increasing Again In The US

    The New York Times (11/14, Mervosh, Goodman, Bosman) reported deaths from COVID-19 are increasing again. The article adds, “More than 1,000 Americans are dying of the coronavirus every day on average, a 50 percent increase in the last month.” The article...
    Full Article
  • Studies Evaluate Role Of Interferons In Coronavirus

    Kaiser Health News (11/13, Szabo) reported on the reasons some people become much more sick with the coronavirus than others. For instance, “in an international study in Science, 10% of nearly 1,000 COVID patients who developed life-threatening pneumonia...
    Full Article
  • Scientists Studying Ways Coronavirus Affects Blood Vessels

    Kaiser Health News (11/13) reported, “Whether it’s strange rashes on the toes or blood clots in the brain, the widespread ravages of COVID-19 have increasingly led researchers to focus on how the novel coronavirus sabotages blood vessels.” As scientists h...
    Full Article
  • SARS-CoV-2 Infection Associated With Wide Spectrum Of Encephalitis, Study Indicates

    Infectious Disease Advisor (11/13, Masoud) reported SARS-CoV-2 infection “is associated with a wide spectrum of encephalitis with varying clinical presentations, responses to treatment, and outcomes.” The findings were published in The Journal of Infectio...
    Full Article
  • Researchers Say A Third Of COVID-19 Survivors Report Ongoing Health Issues Two Months After Being Released From The Hospital

    CNN (11/14, Erdman, Howard) reported researchers surveyed COVID-19 survivors two months after they were treated and released from hospitals in Michigan and found that a third “reported ongoing health issues, such as cough, new or worsening conditions and...
    Full Article
  • Moderna’s Coronavirus Vaccine Candidate Appears To Be 94.5% Effective In Interim Analysis

    USA Today (11/16, Weintraub) reports Moderna’s SARS-CoV-2 vaccine candidate “appears to be 94.5% effective against the” virus. The vaccine was “developed in collaboration with the U.S. government” and, like Pfizer’s coronavirus vaccine candidate, relies o...
    Full Article
  • State Governments Reportedly Lack Adequate Funding To Handle Coronavirus Vaccine Training, Administration

    The New York Times (11/14, A1, Goodnough, Kaplan) reported, “With the prospect that a coronavirus vaccine will become available for emergency use as soon as next month, states and cities are warning that distributing the shots to an anxious public could b...
    Full Article
  • Expert Says Higher Demand For Coronavirus Testing May Lead To Delays In Results

    The Hill (11/12, Sullivan) reports Julie Khani, president of the American Clinical Laboratory Association, said in a statement, “The surge in demand for [coronavirus] testing will mean that some members could reach or exceed their current testing capaciti...
    Full Article
  • «
  • 241
  • 242
  • 243
  • 244
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id